Weiping Liu Selected Research

Epstein-Barr Virus Infections

1/2020	Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populations.
8/2002	[Analyzing of prognosis of intestinal T-cell lymphoma].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Weiping Liu Research Topics

Disease

58	Neoplasms (Cancer) 05/2024 - 08/2002
14	Lymphoma (Lymphomas) 12/2023 - 08/2002
12	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2023 - 12/2013
12	Breast Neoplasms (Breast Cancer) 01/2020 - 09/2007
11	Infections 02/2024 - 06/2007
9	T-Cell Lymphoma (Lymphoma, T Cell) 01/2024 - 08/2002
9	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 01/2014
7	Hodgkin Disease (Hodgkin's Disease) 03/2024 - 04/2014
7	Disease Progression 10/2023 - 12/2014
7	Multiple Myeloma 10/2023 - 05/2019
7	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2007
7	Glioma (Gliomas) 01/2021 - 12/2007
6	Extranodal NK-T-Cell Lymphoma 01/2024 - 07/2013
6	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2024 - 01/2018
5	Carcinogenesis 01/2023 - 06/2013
5	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 01/2018
5	Carcinoma (Carcinomatosis) 05/2022 - 07/2003
5	Cognitive Dysfunction 09/2021 - 01/2018
5	Epilepsy (Aura) 01/2021 - 01/2013
5	Primary Ovarian Insufficiency 01/2021 - 01/2018
4	Birth Weight (Birth Weights) 11/2023 - 02/2017
4	COVID-19 01/2022 - 01/2020
4	Inflammation (Inflammations) 01/2021 - 03/2015
3	Pituitary Neoplasms (Pituitary Adenoma) 01/2023 - 08/2005
3	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2014
3	Lymphatic Metastasis 01/2021 - 01/2014
3	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2021 - 07/2017
3	Body Weight (Weight, Body) 08/2020 - 02/2008
3	Status Epilepticus (Complex Partial Status Epilepticus) 01/2019 - 11/2014
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2018 - 04/2015
3	Hypoxia (Hypoxemia) 06/2018 - 01/2013
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2018 - 08/2002
3	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2016 - 10/2010
3	Adenocarcinoma 01/2015 - 01/2014
3	Colorectal Neoplasms (Colorectal Cancer) 08/2014 - 01/2014
3	Type 2 Diabetes Mellitus (MODY) 01/2014 - 10/2007
2	Hepatitis B 02/2024 - 12/2023
2	Nervous System Diseases (Neurological Disorders) 01/2024 - 01/2021
2	Neutropenia 10/2023 - 02/2017
2	Sepsis (Septicemia) 10/2023 - 07/2020
2	Liver Neoplasms (Liver Cancer) 01/2023 - 03/2016
2	Monoclonal Gammopathy of Undetermined Significance 01/2022 - 05/2019
2	Pain (Aches) 06/2021 - 01/2016

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2007
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2005
7	Messenger RNA (mRNA)IBA 01/2022 - 08/2005
6	Vincristine (Oncovin)FDA LinkGeneric 12/2022 - 07/2012
6	Asparaginase (Elspar)FDA Link 09/2022 - 07/2012
6	EnzymesIBA 01/2022 - 09/2007
5	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 11/2014
5	RNA (Ribonucleic Acid)IBA 12/2023 - 12/2014
5	Dexamethasone (Maxidex)FDA LinkGeneric 10/2023 - 07/2013
5	Rituximab (Mabthera)FDA Link 12/2022 - 04/2013
5	Environmental Pollutants (Pollutants, Environmental)IBA 01/2022 - 01/2014
4	Anti-Bacterial Agents (Antibiotics)IBA 02/2024 - 11/2019
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2024 - 01/2012
4	CytokinesIBA 01/2024 - 01/2017
4	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2019
4	Prednisone (Sone)FDA LinkGeneric 12/2022 - 07/2012
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2022 - 07/2013
4	CateninsIBA 04/2022 - 01/2014
4	AntioxidantsIBA 01/2021 - 12/2007
4	Immunoglobulins (Immunoglobulin)IBA 05/2019 - 01/2015
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 07/2013
4	DDTIBA 02/2017 - 01/2014
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2024 - 05/2022
3	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 06/2006
3	Hepatitis B Surface Antigens (HBsAg)FDA Link 02/2024 - 09/2015
3	daratumumabIBA 10/2023 - 01/2021
3	liposomal doxorubicin (Doxil)FDA Link 12/2022 - 01/2021
3	SoilIBA 01/2022 - 12/2014
3	Immunoglobulin M (IgM)IBA 01/2022 - 12/2014
3	ImmunosorbentsIBA 01/2022 - 09/2007
3	Hormones (Hormone)IBA 01/2022 - 01/2019
3	Anaplastic Lymphoma KinaseIBA 01/2021 - 07/2017
3	HMGB1 Protein (HMG1)IBA 10/2019 - 01/2018
3	Pilocarpine (Ocusert)FDA LinkGeneric 01/2019 - 11/2014
3	Superoxide DismutaseIBA 01/2017 - 01/2002
3	Dichlorodiphenyl Dichloroethylene (DDE)IBA 03/2016 - 01/2014
3	PlatinumIBA 05/2015 - 10/2008
2	Gemcitabine FDA Link 03/2024 - 12/2014
2	Circulating Tumor DNAIBA 01/2024 - 01/2022
2	Bortezomib (Velcade)FDA Link 01/2023 - 01/2021
2	ProdrugsIBA 01/2023 - 05/2022
2	Antiviral Agents (Antivirals)IBA 11/2022 - 01/2022
2	AnthracyclinesIBA 09/2022 - 01/2021
2	Everolimus FDA Link 07/2022 - 01/2018
2	Cisplatin (Platino)FDA LinkGeneric 05/2022 - 01/2013
2	pegaspargase (Oncaspar)FDA Link 01/2022 - 02/2017
2	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 01/2022 - 02/2021
2	Surface Antigens (Surface Antigen)IBA 01/2022 - 09/2015
2	CollagenIBA 08/2021 - 03/2019
2	Nucleic AcidsIBA 02/2021 - 12/2020

Therapy/Procedure

30	Therapeutics 03/2024 - 01/2007
19	Drug Therapy (Chemotherapy) 12/2023 - 07/2012
7	Hematopoietic Stem Cell Transplantation 11/2023 - 02/2019
6	Stem Cell Transplantation 01/2024 - 07/2017
6	Radiotherapy 01/2022 - 07/2012
4	Transplantation 05/2018 - 10/2011
2	Immunotherapy 02/2021 - 08/2019